A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...
T cell engagers, including Imdelltra, show promise in small cell lung cancer, outperforming chemotherapy in trials and changing the standard of care. Antibody-drug conjugates like I-DXd and ABBV-706 ...
First UK trial of anti-TNF therapy for patients who take or have taken checkpoint inhibitor treatments of cancer now open for recruitment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results